Graham J, Earnshaw S, Lim J, Luthra R, Borker R. Cost-effectiveness of afatinib versus erlotinib in the first-line treatment of patients with metastatic non-small cell lung cancer with EGFR Exon 19 deletion mutations. JCP. 2016 May;2(4):31-9.
Grubb NR, Sutherland GR, Fleming A, Campanella C, Fox KAA, Sinclair C. Doppler tissue imaging for non-invasive optimisation of graft functions after dynamic cardiomyoplasty. Poster presented at the Medical Research Society Communications Meeting; April 13, 1994. [abstract] Clin Sci (Lond). 1994 Dec 1; 87(s31):38. doi: 10.1042/cs045038P_pt2